See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Social Media
Floods
Donald Trump
Natural Disasters
Amazon
Facebook
MLB
Boxing
Stock Markets
Artificial Intelligence
Taxes
Prime Day
Published • loading... • Updated

Korean startup Curogen seeks global expansion, new funding to back autoimmune drugs

Summary by Endpoints News
A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US. Curogen, based in Seoul and backed by local investors, announced Monday that it plans to open ...
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All
Left
Center
Right
Endpoints NewsEndpoints News
Reposted by
endpoints.newsendpoints.news

Korean startup Curogen seeks global expansion, new funding to back autoimmune drugs

A South Korean biotech working on multi-specific autoimmune disease treatments is looking to make a leap into the US. Curogen, based in Seoul and backed by local investors, announced Monday that it plans to open ...

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Endpoints News broke the news in on Monday, June 2, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Seoul icon

Seoul

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal